Free Delivery Over $100
|
|
|||
|
||||
OverviewRybelsus (semaglutide) is a medication used to treat type 2 diabetes. It has a spot with a class of drugs known as glucagon-like peptide-1 (GLP-1) receptor agonists. Rybelsus is a GLP-1 receptor agonist. GLP-1 is a trademark substance in the body that coordinates insulin levels and glucose. One conspicuous component of Rybelsus is that it comes in tablet structure, making it special corresponding to various other GLP-1 receptor agonists that are routinely coordinated by mixture. CLICK BUY TO GET THIS PRODUCT Full Product DetailsAuthor: David LawsonPublisher: Independently Published Imprint: Independently Published Dimensions: Width: 15.20cm , Height: 0.20cm , Length: 22.90cm Weight: 0.050kg ISBN: 9798873972630Pages: 28 Publication Date: 04 January 2024 Audience: General/trade , General Format: Paperback Publisher's Status: Active Availability: In stock  We have confirmation that this item is in stock with the supplier. It will be ordered in for you and dispatched immediately. Table of ContentsReviewsAuthor InformationTab Content 6Author Website:Countries AvailableAll regions |
||||
